Changes

Interferon For Treatment of Melanoma

6 bytes added, 07:39, 17 June 2011
/* Concept Table */
==Concept Table==
{|border="2" cellspacing="0" cellpadding="4" width="50100%"
| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''S.No'''</center>
| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''Concept-1'''</center>
|}
===French Keywords Concept table===
{|border="2" cellspacing="0" cellpadding="4" width="50100%"
| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''S.No'''</center>
| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''Concept-1'''</center>
===German Keywords Concept Table===
{|border="2" cellspacing="0" cellpadding="4" width="50100%"
| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''S.No'''</center>
| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''Concept-1'''</center>
* '''Relevant IPC classes'''
{|border="2" cellspacing="0" cellpadding="4" width="75100%"
|align = "center" bgcolor = "#99CCFF" colspan = "4"|'''IPC'''
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''Sr. No.'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class Code'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class definition'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class coverage'''
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''1'''
|align = "center"|A61K003819
|align = "center"|Medicinal preparations containing peptides - Cytokines; Lymphokines; Interferons
|align = "center"|Broad
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''2'''
|align = "center"|A61K003821
|align = "center"|Medicinal preparations containing peptides Interferon
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''3'''
|align = "center"|C07K001452
|align = "center"|Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof - Cytokines; Lymphokines; Interferons
|align = "center"|Broad
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''4'''
|align = "center"|C07K014555
|align = "center"|Peptides having more than 20 amino acids - Interferon
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''5'''
|align = "center"|C07K001456
|align = "center"|Peptides having more than 20 amino acids - IFN-alpha
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''6'''
|align = "center"|C07K014565
|align = "center"|Peptides having more than 20 amino acids - IFN-beta
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''7'''
|align = "center"|C07K001457
|align = "center"|Peptides having more than 20 amino acids - IFN-gamma
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''8'''
|align = "center"|A61P003500
|align = "center"|Therapeutic activity of chemical compounds or medicinal preparations -antineoplastic agents
* '''Relevant ECLA classes'''
{|border="2" cellspacing="0" cellpadding="4" width="75100%"
|align = "center" bgcolor = "#99CCFF" colspan = "4"|'''ECLA'''
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''Sr. No.'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class Code'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class definition'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class coverage'''
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''1'''
|align = "center"|A61K003819
|align = "center"|Medicinal preparations containing peptides - Cytokines; Lymphokines; Interferons
|align = "center"|Broad
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''2'''
|align = "center"|A61K003821
|align = "center"|Medicinal preparations containing Interferon
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''3'''
|align = "center"|A61K38/21A
|align = "center"|Medicinal preparations containing IFN-alpha
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''4'''
|align = "center"|A61K38/21B
|align = "center"|Medicinal preparations containing IFN-beta
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''5'''
|align = "center"|A61K38/21C
|align = "center"|Medicinal preparations containing IFN-gamma
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''6'''
|align = "center"|C07K001452
|align = "center"|Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof - Cytokines; Lymphokines; Interferons
|align = "center"|Broad
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''7'''
|align = "center"|C07K014555
|align = "center"|Peptides having more than 20 amino acids - Interferon
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''8'''
|align = "center"|C07K001456
|align = "center"|Peptides having more than 20 amino acids - IFN-alpha
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''9'''
|align = "center"|C07K014565
|align = "center"|Peptides having more than 20 amino acids - IFN-beta
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''10'''
|align = "center"|C07K001457
|align = "center"|Peptides having more than 20 amino acids - IFN-gamma
|align = "center"|Specific
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''11'''
|align = "center"|C07K014715G
|align = "center"|Receptors; Cell surface antigens; Cell surface determinants - for interferons -
* '''Relevant US classes'''
{|border="2" cellspacing="0" cellpadding="4" width="50100%"
|align = "center" bgcolor = "#99CCFF" colspan = "3"|'''US class'''
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''Sr. No.'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class Code'''|align = "center" bgcolor = "#C0C0C099ccff"|'''Class definition'''
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''1'''
|align = "center"|4240854
|align = "center"|DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS - this subclass provides for patents which broadly claim interferon or a method of treatment of interferon where the classification of the interferon as alpha, beta or gamma interferon is impossible
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''2'''
|align = "center"|4242811
|align = "center"| DRUG, BIO-AFFCTING AND BODY TREATING COMPOSITIONS - Virus (e.g., interferon-inducing virus, etc.)
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''3'''
|align = "center"|42400141
|align = "center"|DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS - Attached to lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interferon, interleukin, macrophage factor, colony stimulating factor, erythropoietin); derivative thereof
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''4'''
|align = "center"|514889
|align = "center"|DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS - INTERFERON INDUCER
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''5'''
|align = "center"|530351
|align = "center"| CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF - Lymphokines, e.g., interferons, interlukins, etc.
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''6'''
|align = "center"|930142
|align = "center"|PEPTIDE OR PROTEIN SEQUENCE - Interferon
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''7'''
|align = "center"|4240851
|align = "center"|LYMPHOKINE - Included in this and the indented subclasses interferon, interleukin and macrophage factors (monokines)
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''8'''
|align = "center"|4240855
|align = "center"|Gamma or immune: This subclass is indented under subclass 85.4. Subject matter in which the interferon is gamma or immune interferon.
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''9'''
|align = "center"|4240856
|align = "center"|Subject matter in which the interferon is beta or fibroblast interferon.
|-
|align = "center" bgcolor = "#C0C0C099ccff"|'''10'''
|align = "center"|4240857
|align = "center"|Subject matter in which the interferon is alpha or leukocyte interferon.
245
edits